Olga N. Miller
Abstract
The ventricular heart rhythm disturbances occurring in individuals with no structural heart abnormality are a pressing issue not only due to their significance, but also due to the lack of clear approaches to treatment of such patients. In actual clinical practice, the physician faces a number of unresolved problems related to both causes and treatment of premature heath beats. This issue requires further research aimed to determine the optimal tactics of management for the specific patient with premature heath beats.
Keywords: premature heart beats, connective tissue disease, mitral valve prolapse.
About the Author
Olga N. Miller 11 Novosibirsk State Medical University, Novosibirsk, Russia
References
1. Nagata Y, Bertrand PB, Levine RA. Malignant Mitral Valve Prolapse:Risk and Prevention of Sudden Cardiac Death. Curr Treat Options Cardiovasc Med. 2022;24(5):61-86.
2. Nagata Y, Bertrand PB, Baliyan V et аl. Abnormal Mechanics Relate toMyocardial Fibrosis and Ventricular Arrhythmias in Patients With Mitral Valve Prolapse. Circ Cardiovasc Imaging 2023;16(4):e014963.
3. Basso C,Iliceto S, Thiene G, Perazzolo Marra M. Mitral Valve Prolapse, Ventricular Arrhythmias, and Sudden Death. Circulation 2019;140(11):952–64.
4. Басаргина Е.Н. Синдром дисплазии соединительной ткани сердцау детей. Вопросы современной педиатрии. 2008;1:129-33.Basargina E.N. Cardiac connective tissue dysplasia syndrome in children. Issues of modern pediatrics. 2008;1:129-33 (in Russian).
5. Мартынов А.И., Поляков Ю.Ф., Николаева В.В. Моделированиеэмоциональной нагрузки у лиц с синдромом дисплазии соединительной ткани сердца. Кардиология. 1999;11:51-8.Martynov A.I., Polyakov Yu.F., Nikolaeva V.V. Modeling emotionalstress in individuals with connective tissue dysplasia syndrome of theheart. Cardiology. 1999;11:51-8 (in Russian).
6. Новикова М.В. Аритмический синдром и ремоделирование миокарда при дисплазии соединительной ткани. Медицинский вестник Северного Кавказа. 2013;9(4):84-5.Novikova M.V. Arrhythmic syndrome and myocardial remodeling inconnective tissue dysplasia. Medical Bulletin of the North Caucasus. 2013;9(4):84-5 (in Russian).
7. Pervichko E, Zinchenko Yu, Martynov A. Peculiarities of EmotionalRegulation with MVP Patients: A Study of the Effects of Rational-Emotive Therapy. Procedia-Social and Behavioral Sciences 2013;78:290-4.
8. Степура О.Б., Остроумова О.Д., Пак Л.С. Аномально расположенные хорды как проявление синдрома дисплазии соединительнойткани сердца. Кардиология. 1997;12:74-6.Stepura O.B., Ostroumova O.D., Pak L.S. Abnormally located chords asa manifestation of cardiac connective tissue dysplasia syndrome. Cardiology. 1997;12:74-6 (in Russian).
9. Cole WG, Chan D, Hichey AJ. Collagen composition of normal andmyxomatous human mitral heart valves. Biochem J 1996;219(2):451- 60.
10. Rambihar S, Sanfilippo AJ, Sasson Z. Mitral chordal-leaflet-myocardialinteractions in mitral valve prolapse. J Am Soc Echocardiogr 2014;27(6):601-7.
11. Perazzolo Marra M, Basso C et al. Morphofunctional Abnormalities ofMitral Annulus and Arrhythmic Mitral Valve Prolapse. Circ CardiovascImaging 2016;9(8):e005030.
12. Sriram CS, Syed FF, Ferguson ME. et al. Malignant bileaflet mitralvalve prolapse syndrome in patients with otherwise idiopathic out-ofhospital cardiac arrest. J Am Coll Cardiol 2013;62(3):222-30.
13. Al’Aref SJ. Differentiation of papillary muscle from fascicular and mitral annular ventricular arrhythmias in patients with and without structural heart disease. Circulation 2015;8(3):616-24.
14. Kitkungvan D, Nabi F, Kim RJ et al. Myocardial Fibrosis in PatientsWith Primary Mitral Regurgitation With and Without Prolapse. J AmColl Cardiol 2018;72(8):823-34.
15. Basso C, Perazzolo Marra M, Rizzo S et al. Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death. Circulation 2015;132(7):556-66.
16. Sanfilippo AJ, Harrigan P, Popovic AD et al. Papillary muscle tractionin mitral valve prolapse: quantitation by two-dimensional echocardiography. J Am Coll Cardiol 1992;19(3):564-71.
17. Nalliah CJ, Mahajan R, Elliott AD et al. Mitral valve prolapse and sudden cardiac death: a systematic review and meta-analysis. Heart 2019;105(2):144-51.
18. Hourdain J, Clavel MA, Deharo JC et аl. Common Phenotype in Patients With Mitral Valve Prolapse Who Experienced Sudden CardiacDeath. Circulation 2018;138(10):1067-9.
19. Dejgaard LA, Skjølsvik ET, Lie ØH et al. The Mitral Annulus Disjunction Arrhythmic Syndrome. J Am Coll Cardiol 2018;72(14):1600-9.
20. Нечаева Г.И., Яковлев В.М., Друк И.В. Нарушения ритма сердцапри недифференцированной дисплазии соединительной ткани.Лечащий врач. 2008;6:2-7.Nechaeva G.I., Yakovlev V.M., Druk I.V. Heart rhythm disturbances inundifferentiated connective tissue dysplasia. Attending doctor. 2008;6:2-7 (in Russian).
21. Нечаева Г.И, Лялюкова Е.А., Дрокина О.В. Кардиоваскулярныесиндромы дисплазии соединительной ткани у лиц молодого возраста: частота регистрации, факторы формирования. Лечащийврач. 2014;6:72-5.Nechaeva G.I., Lyalukova E.A., Drokina O.V. Cardiovascular syndromesof connective tissue dysplasia in young people: frequency of registration,formation factors. Attending doctor. 2014;6:72-5 (in Russian).
22. Желтухова Е.В. Клинико-электрофизиологическая характеристика манифестных и латентных нарушений ритма сердца и проводимости сердца при пролапсе митрального клапана. Автореф. дис. …канд. мед. наук. Томск, 1989.Zheltukhova E.V. Clinical and electrophysiological characteristics ofmanifest and latent disturbances of heart rhythm and cardiac conduction in mitral valve prolapse. Author's abstract. dis. ... Cand. Sci.(Med.). Tomsk, 1989 (in Russian).
23. Земцовский Э.В., Горбунова В.Н. Еще раз о наследственных нарушениях соединительной ткани и правомерности диагноза «Синдрома дисплазии соединительной ткани». Новые Санкт-Петербургские врачебные ведомости. 2013;4:42-50.Zemtsovsky E.V., Gorbunova V.N. Once again about hereditary connective tissue disorders and the validity of the diagnosis of “Connective tissue dysplasia syndrome.” New St. Petersburg medical statements. 2013;4:42-50 (in Russian).
24. Timofeeva EP, Kartseva TV, Ryabichenko TI, Skosyreva GA. Modernview of the undifferentiated connective tissue dysplasia. Russian Bulletin of Perinatology and Pediatrics 2012;4(1):112-6.
25. Yakovlev VM, Khait GYa, Gusev SV. Electro-physiological remodelingof the left ventricle in hereditary cardiac connective tissue dysplasia:conceptual model ofelectrogenesis. Medical Bulletin of the North Caucasus 2008;2:68-72.
26. Cordas TA, Rossi EG. Mitral valve prolapse and panic disorder. ArgBras Cardiol 2001;56(2):139-42.Литература / References
27. Domnitskaya TM, Dyachenko AV, Domnitsky MV. The clinical significance of the use of magnesium orotate in adolescents with the syndrome of the cardiac connective tissue dysplasia. Cardiology. 2005;3:76-81.
28. Григорян С.В., Адамян Л.А., Степуренко Л.А. Синдром пролабирования митрального клапана и нарушение ритма сердца. Кардиология. 1996;12:54-5.Grigoryan S.V., Adamyan L.A., Stepurenko L.A. Mitral valve prolapse syndrome and cardiac arrhythmia. Cardiology. 1996;12:54-5 (in Russian).
29. Schaal SF. Ventricular arrhythmias in patients with mitral valve prolapse. Cardiovasc Clin 1992;22:307-16.
30. Национальные рекомендации по диагностике и лечению наследственных нарушений соединительной ткани. 2012.National recommendations for the diagnosis and treatment of hereditary connective tissue disorders. 2012 (in Russian).
31. Bonow RO, Carabello B, Chatterjee K et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patientswith valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 2008;52(13):e1-142.
32. Кручина Т.К., Ковальчук Т.С., Васичкина Е.С., Татарский Б.А.Опыт применения пропафенона у новорожденных и детей раннеговозраста с нарушениями ритма сердца. Российский кардиологический журнал. 2020;25(7):3462.Kruchina T.K., Kovalchuk T.S., Vasichkina E.S., Tatarsky B.A. Experience with the use of propafenone in newborns and young children withcardiac arrhythmias. Russian Journal of Cardiology. 2020;25(7):3462(in Russian).
33. Pedersen CT, Kay GN, Kalman J et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace 2014;16(9):1257-83.
34. Фогорос Р.Н. Антиаритмические средства. Изд. 2-е. М.: Бином, 2009.Fogoros R.N. Antiarrhythmic drugs. Ed. 2nd. M.: Binom, 2009 (inRussian).
For citation:Miller O.N. Premature heart beats in patients with the connective tissue disease. Clinical analysis in general medicine. 2024; 5 (2): 15–20 (In Russ.). DOI: 10.47407/kr2023.5.2.00383
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
